Skip to content
Home/Companies/Biotech/Curasight A/S

Curasight A/S

Biotech·Denmark·Exited 2020·Held 6yr
Entry
2014
Hold
6yr
Exit
2020

Who owns Curasight A/S?

Curasight A/S is a Danish Biotech company, formerly owned by PreSeed Ventures, exited in 2020 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
PreSeed Ventures
Investor
PreSeed Ventures
PreSeed Ventures (early) · 2000 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2020

More from PreSeed Ventures (early)

Other portfolio companies in the same fund.

GoMore
Exited 2022
MobilityDenmark· 2014
to Nordic Secondary Fund
Penneo
Exited 2020
LegalTechDenmark· 2014
MinervaX
MinervaX
Active
BiotechDenmark· 2010
Trustpilot
Exited 2021
TMTDenmark· 2008

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Curasight A/S?

Curasight A/S was formerly owned by PreSeed Ventures, exited in 2020. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue